Geron
GERN
$4.08
Share price
3.82%
Change (1 day)
59.38%
Change (1 year)
Categories
Geron (GERN) - Net assets
Net assets on the balance sheet as of December 2023 : $0.24 B
According to Geron's latest financial reports the company has $0.24 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Geron - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.24 B | 209.94% |
| 2022-12-31 | $79.99 M | -36.72% |
| 2021-12-31 | $0.12 B | -40.07% |
| 2020-12-31 | $0.21 B | 56.08% |
| 2019-12-31 | $0.13 B | -23.96% |
| 2018-12-31 | $0.17 B | 71.23% |
| 2017-12-31 | $0.10 B | -15.18% |
| 2016-12-31 | $0.12 B | -13.89% |
| 2015-12-31 | $0.14 B | 8.73% |
| 2014-12-31 | $0.13 B | 118.74% |
| 2013-12-31 | $59.75 M | -30.23% |
| 2012-12-31 | $85.65 M | -41.57% |
| 2011-12-31 | $0.14 B | -23.94% |
| 2010-12-31 | $0.19 B | 11.68% |
| 2009-12-31 | $0.17 B | 2.45% |
| 2008-12-31 | $0.16 B | -18.1% |
| 2007-12-31 | $0.20 B | 18.26% |
| 2006-12-31 | $0.17 B | -1.01% |
| 2005-12-31 | $0.17 B | 43.94% |
| 2004-12-31 | $0.12 B | 14.8% |
| 2003-12-31 | $0.10 B | 257.5% |
| 2002-12-31 | $29.74 M | -51.67% |
| 2001-12-31 | $61.54 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $22.74 B | 9,074.87% | 🇺🇸 USA |
 Incyte INCY | $5.18 B | 1,993.11% | 🇺🇸 USA |
 CTI BioPharma
CTIC | -$25.35 M | -110.22% | 🇺🇸 USA |
 Bio-Techne TECH | $1.96 B | 691.92% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $2.23 M | -99.10% | 🇺🇸 USA |